BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Deals

  OBI Pharma Announces Acquisition Of TH-3424 From Threshold

  June 1, 2017

   · 

  4 min read
• FDA

  BioMarin Release: European Commission (EC) Approves Brineura (Cerliponase Alfa), The First Treatment For CLN2 Disease, A Form Of Batten Disease And Ultra-Rare Brain Disorder In Children

  June 1, 2017

   · 

  8 min read
• Business

  Gritstone Oncology Expands Scientific Advisory Board With Appointment Of Immuno-Oncology Experts James L. Gulley And Alessandro Sette

  June 1, 2017

   · 

  6 min read
• Drug Development

  Cyteir Therapeutics Announces Study Showing RAD51 Modulators Protect Diabetic Mice From Type 1 Diabetes (T1D)

  June 1, 2017

   · 

  4 min read
• Drug Development

  Celgene And Acceleron Pharma Complete Target Enrollment In The MEDALIST And BELIEVE Phase III Studies Of Luspatercept In Myelodysplastic Syndromes And Beta-Thalassemia

  June 1, 2017

   · 

  7 min read
• Drug Development

  Arthromeda Completes Successful Preclinical Studies And Closes Funding For Its Arthrosight Patient-Specific Navigation Platform

  June 1, 2017

   · 

  3 min read
• Drug Development

  Eleven Bio Announces Data And Safety Monitoring Board (DSMB) Recommendation To Continue Phase III Registration Trial With Vicinium In Non-Muscle Invasive Bladder Cancer Based On Review Of Safety And Efficacy Data

  June 1, 2017

   · 

  5 min read
• Drug Development

  H3 Biomedicine’s Preclinical Data Highlighting Novel Discovery Research Around Splicing Modulators Published In Current Issue Of Nature Communications

  June 1, 2017

   · 

  3 min read
• Pharm Country

  QuintilesIMS Institute Study: New Class Of Oncology Therapies Provides More Options, Better Outcomes Than Any Point In History

  June 1, 2017

   · 

  6 min read
• Business

  Trianni Signs Agreement With Massachusetts General Hospital For Use Of The Trianni Mouse In HIV Vaccine Research

  June 1, 2017

   · 

  1 min read